Global Stem Cells Group, Inc. and BioHeart, Inc. Launch Clinical Trial for COPD Stem Cell Therapies

Global Stem Cells Group and Bioheart announce the launch of a unique clinical trial called “Adipose Derived Cells for Chronic Obstructive Pulmonary Disease.” Global Stem Cells Group, Inc. and BioHeart, Inc. announce the launch of a clinical trial for the treatment of Chronic Obstructive Pulmonary Disease (COPD) using adipose-derived stem cell technology. The clinical trials…